All articles tagged with #nhs
Mark Cain, 45, has been charged with the murder of his wife, GP Hannah Terry, after her body was found in their home in Dersingham, Norfolk. Police confirmed she suffered blunt force head injuries and neck compression. Cain appeared in magistrates' court and was remanded in custody ahead of a crown court hearing.
NHS England has referred ten mental health trusts to the Care Quality Commission (CQC) after a review found they failed to follow proper consent procedures for the Oxevision monitoring system. This development emerged during the Lampard Inquiry into deaths in Essex mental health units, with Baroness Lampard considering interim recommendations if patient safety risks are identified.
Baroness Kate Lampard may issue interim recommendations within weeks after hearing evidence on the Oxevision monitoring system and inpatient safety. The inquiry, which covers over 2,000 deaths in Essex mental health services between 2000 and 2023, is examining whether remote monitoring technology compromises patient dignity and safety. Hearings are scheduled for October 5-15, with a decision on interim measures expected before the final report in 2028.
Artificial intelligence is reshaping dermatology services in the UK by accelerating skin cancer detection and reducing unnecessary procedures. At St Luke's Hospital in Bradford, the DERM system has increased patient throughput by one-third and cut unnecessary biopsies by 10%. A broader study presented in Vienna suggests autonomous AI could free up specialist time for over 8,500 additional appointments across two hospitals, addressing severe workforce shortages in dermatology.
Charlotte Howard, a 52-year-old horticulturist from West Lavington, Wiltshire, is considering paying up to £9,000 for private breast reduction surgery after being denied NHS coverage. Her breasts grew from a 32B to a 40GG during menopause, causing chronic back pain, skin rashes, and public harassment. The NHS declined to comment on her specific case, stating that such procedures are not routinely commissioned but are assessed individually based on clinical need and resource fairness.
An NHS anaesthetist used Google's Gemini AI to identify a rare vitamin B6 deficiency in his mother, a Parkinson's patient suffering from continuous seizures. This discovery led to an intravenous supplement that stopped the seizures and restored her cognitive function. While the case highlights AI's potential in clinical settings, experts urge caution and emphasize the need for formal trials to validate the link between B6 deficiency and Parkinson's medications.
The NHS is piloting a rapid genomic test that reduces brain tumour diagnosis times from up to eight weeks to two hours, allowing surgeons to make decisions during operations. Developed by the University of Nottingham, the test uses Oxford Nanopore technology to analyze DNA samples in a shoebox-sized machine. It is currently being tested in five specialist centres across England, with plans for wider rollout.
Bristol Foundation NHS Trust is investigating three nurses and one doctor for accessing the medical records of Oliver McGowan, an 18-year-old autistic boy who died in 2016, without legitimate professional reasons. His mother, Paula McGowan, reported that 38 individuals accessed his data since his death, with 637 items viewed and 67 printed. While most access was linked to legal proceedings or inquests, the trust is formally investigating three nurses who had no involvement in his care. One nurse allegedly accessed the files out of general interest in anti-psychotic drugs. A former doctor has self-referred to the General Medical Council. The trust has voluntarily referred itself to the Information Commissioner's Office and apologized for the distress caused. This case highlights ongoing concerns about unauthorized access to sensitive patient data in the NHS, following recent high-profile breaches and a new zero-tolerance policy from NHS England.
NHS England has mandated immediate suspension and system lockouts for staff suspected of accessing patient records without valid clinical reasons. This 'zero-tolerance' policy follows high-profile breaches involving victims of the Nottingham and Southport attacks, as well as a recent case in Bristol where records of a deceased teenager were accessed years after his death. Sir Jim Mackey, chief executive of NHS England, ordered all trusts to implement these measures to prevent further data breaches and protect confidential information.
The NHS has launched a two-year pilot for a rapid genomic test that classifies brain tumours in two hours, reducing the standard diagnostic wait from up to eight weeks. Developed by the University of Nottingham, the technology uses Oxford Nanopore sequencing to provide surgeons with critical genetic data during operations, potentially accelerating treatment and clinical trial access for the 12,000 UK patients diagnosed annually.
A new genomic test is cutting brain tumour diagnosis times from up to eight weeks to two hours. The NHS is piloting the technology at five specialist centres in England, allowing surgeons to make critical decisions during operations. Developed by the University of Nottingham, the test uses Oxford Nanopore sequencing to analyse tumour DNA rapidly, potentially accelerating treatment and clinical trial access for the 12,000 UK patients diagnosed annually.
A 20-year-old student accidentally took two over‑the‑counter medicines that both contained paracetamol, causing multi‑organ failure and liver damage. He was placed on life support and dialysis, later transferred to King’s College Hospital where his condition gradually improved. He ultimately recovered enough to relearn walking and speaking, and his family now raises awareness and funds for ICU care.
UK NHS data cited by Rethink Mental Illness show adults under 75 with severe mental illness die about 15–20 years earlier than peers, largely from preventable physical diseases (liver, respiratory, cardiovascular diseases, cancer) and suicide. The gap is driven by poverty, housing, smoking, weight gain from medications, physical inactivity, and fragmented care, with 'diagnostic overshadowing' delaying investigation of physical symptoms. Advocates call for routine physical health checks and integrated, mental-health–informed care as government plans to act move forward.
UK researchers are testing in-home dementia care tech in an NHS trial led by the UK Dementia Research Institute and Imperial College London. Jyoti and Bharat Patel live in a sensor-packed home where door, movement, kitchen, and sleep data are gathered via devices including a smart mattress, socks and a watch to help clinicians spot early health changes, support independence, and reduce hospital visits. The programme costs about £2,000 per year and does not record audio or video, aiming to balance privacy with better care; if scaled up, it could affect nearly a million people living with dementia in the UK.
A government-commissioned review proposes a needs-based, triage approach to ADHD and autism services in the NHS, offering targeted early support without formal diagnoses for milder cases and referring only those who would benefit from medication to clinics. Critics say it effectively rationes care and risks driving people to self-diagnose, while supporters argue early non-diagnostic help in schools and workplaces can help. The final report is due soon amid long NHS waiting lists and calls to curb rising diagnoses and costs.